Menta Capital’s Can-Fite BioPharma American Depositary Shares CANF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
– Sell
-14
Closed -$100K – 819
2016
Q4
$100K Sell
14
-1
-7% -$7.01K 0.01% 830
2016
Q3
$115K Hold
15
– – 0.01% 784
2016
Q2
$116K Buy
15
+2
+15% +$16.9K 0.02% 814
2016
Q1
$106K Hold
13
– – 0.01% 869
2015
Q4
$113K Buy
13
+9
+225% +$90.5K 0.01% 815
2015
Q3
$51K Hold
4
– – 0.01% 694
2015
Q2
$27K Hold
4
– – ﹤0.01% 651
2015
Q1
$27K Buy
+4
New +$48.1K ﹤0.01% 674

Other funds holding CANF

Menta Capital's CANF Position: Q1 2017 in Review

Menta Capital sold out of Can-Fite BioPharma American Depositary Shares (CANF) in Q1 2017, closing a stake of 14 shares — an estimated $100K sold.

Menta Capital first reported a position in CANF in Q1 2015 and held it in 8 quarters. The position peaked at $116K in Q2 2016. 3 funds tracked by Wall St. Rank hold CANF as of Q1 2017.

  • Menta Capital reported no remaining Can-Fite BioPharma American Depositary Shares position as of Q1 2017 after selling out during the quarter.
  • Menta Capital sold 14 Can-Fite BioPharma American Depositary Shares shares in Q1 2017, an estimated $100K.
  • Menta Capital first reported a position in Can-Fite BioPharma American Depositary Shares in Q1 2015 and held it in 8 quarters.
  • Menta Capital's Can-Fite BioPharma American Depositary Shares position peaked at $116K in Q2 2016.
  • 3 funds tracked by Wall St. Rank held Can-Fite BioPharma American Depositary Shares as of Q1 2017.

Based on Menta Capital's 13F filing for Q1 2017, filed 12 May 2017.